20160128 EGA Regulatory and Scientific Affairs Conferenc

Vigilance saves lives! More focus needed on sustainability and patient engagement

24 January 2018

National authorities, regulators, industry leaders and key stakeholders gathered in […]

Read more

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come

18 January 2018

Geneva, 18 January 2018 – Today, the AMR Industry Alliance […]

Read more

What Challenges Should Biosimilar Companies Expect In 2018?

10 January 2018


2018 Outlook: Biosimilar Trends To Watch

3 January 2018


Did The 2017 Biosimilar Industry Pave The Way For A Productive 2018?

28 December 2017


Value-added medicines: how repurposed medicines bring value to patients and pharmacists

21 December 2017


Pharmacovigilance, traceability and building trust in biosimilar medicines

21 December 2017


The associations representing the European and British life science industry (AESGP, ABPI, BGMA, BIA, EBE, EFPIA, EUCOPE, EuropaBio, Medicines for Europe, PAGB, Vaccines Europe) have today launched a joint policy document on the potential impact of the United Kingdom’s exit from the European Union

14 December 2017

Today, organisations representing the life science industry in the EU […]

Read more

European Commission launches: “What I need to know about Biosimilar Medicines – Information for patients”, in 23 EU languages

29 November 2017

The European Commission launched today additional translations of the Q&A […]

Read more

Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit

28 November 2017

The associations representing the European and British life science industry […]

Read more

Subscribe to our newsletter